Morpholino

MO2-psen2

ID
ZDB-MRPHLNO-080421-2
Name
MO2-psen2
Previous Names
  • MoPS2TIn (1)
Target
Sequence
5' - GTGACTGAATTTACATGAAGGATGA - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-psen2
Expressed Gene Anatomy Figures
elavl3 Fig. 4 from Nornes et al., 2009
foxd3 Fig. 4 from Nornes et al., 2009
neurog1 Fig. 1 from Nornes et al., 2009
Phenotype
Phenotype resulting from MO2-psen2
Phenotype Fish Figures
DoLA increased amount, abnormal WT + MO2-psen2 Fig. 6 from Nornes et al., 2009
Fig. 4 from Nornes et al., 2008
fourth ventricle increased size, abnormal WT + MO2-psen2 Fig. 1 from Nornes et al., 2009
hindbrain hydrocephalic, abnormal WT + MO2-psen2 Fig. 1 from Nornes et al., 2009
melanocyte decreased amount, abnormal WT + MO2-psen2 Fig. 1 from Nornes et al., 2009
melanocyte spatial pattern, abnormal WT + MO2-psen2 Fig. 2 from Nornes et al., 2009
midbrain hydrocephalic, abnormal WT + MO2-psen2 Fig. 1 from Nornes et al., 2009
neural crest cell decreased amount, abnormal WT + MO2-psen2 Fig. 4 from Nornes et al., 2009
neural crest cell development disrupted, abnormal WT + MO2-psen2 Fig. 4 from Nornes et al., 2009
neuron increased amount, abnormal WT + MO2-psen2 Fig. 4 from Nornes et al., 2009
post-vent region melanocyte decreased amount, abnormal WT + MO2-psen2 Fig. 3 from Nornes et al., 2009
Rohon-Beard neuron axonal transport of mitochondrion decreased process quality, abnormal s1102tEt; s1999tTg + MO2-psen2 Figure 5 with image from Barazzuol et al., 2023
somitogenesis disrupted, abnormal WT + MO2-psen2 text only from Nornes et al., 2009
tectal ventricle increased size, abnormal WT + MO2-psen2 Fig. 1 from Nornes et al., 2009
trunk melanocyte decreased amount, abnormal WT + MO2-psen2 Fig. 2,  Fig. 3 from Nornes et al., 2009
whole organism decreased size, abnormal WT + MO2-psen2 Fig. 1 from Nornes et al., 2009
Phenotype of all Fish created by or utilizing MO2-psen2
Phenotype Fish Conditions Figures
post-vent region melanocyte decreased amount, abnormal WT + MO2-psen2 standard conditions Fig. 3 from Nornes et al., 2009
somitogenesis disrupted, abnormal WT + MO2-psen2 standard conditions text only from Nornes et al., 2009
midbrain hydrocephalic, abnormal WT + MO2-psen2 standard conditions Fig. 1 from Nornes et al., 2009
tectal ventricle increased size, abnormal WT + MO2-psen2 standard conditions Fig. 1 from Nornes et al., 2009
neuron increased amount, abnormal WT + MO2-psen2 standard conditions Fig. 4 from Nornes et al., 2009
neural crest cell development disrupted, abnormal WT + MO2-psen2 standard conditions Fig. 4 from Nornes et al., 2009
DoLA increased amount, abnormal WT + MO2-psen2 standard conditions Fig. 6 from Nornes et al., 2009
Fig. 4 from Nornes et al., 2008
melanocyte decreased amount, abnormal WT + MO2-psen2 standard conditions Fig. 1 from Nornes et al., 2009
neural crest cell decreased amount, abnormal WT + MO2-psen2 standard conditions Fig. 4 from Nornes et al., 2009
whole organism decreased size, abnormal WT + MO2-psen2 standard conditions Fig. 1 from Nornes et al., 2009
hindbrain hydrocephalic, abnormal WT + MO2-psen2 standard conditions Fig. 1 from Nornes et al., 2009
fourth ventricle increased size, abnormal WT + MO2-psen2 standard conditions Fig. 1 from Nornes et al., 2009
trunk melanocyte decreased amount, abnormal WT + MO2-psen2 standard conditions Fig. 2,  Fig. 3 from Nornes et al., 2009
melanocyte spatial pattern, abnormal WT + MO2-psen2 standard conditions Fig. 2 from Nornes et al., 2009
Rohon-Beard neuron axonal transport of mitochondrion decreased process quality, abnormal s1102tEt; s1999tTg + MO2-psen2 control Figure 5 with image from Barazzuol et al., 2023
trunk melanocyte decreased amount, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2009
melanocyte decreased amount, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
fourth ventricle increased size, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
whole organism decreased size, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
hindbrain hydrocephalic, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
melanocyte spatial pattern, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 2 from Nornes et al., 2009
midbrain hydrocephalic, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
tectal ventricle increased size, abnormal WT + MO2-psen2 + MO3-psen1 standard conditions Fig. 1 from Nornes et al., 2009
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.